322 related articles for article (PubMed ID: 21749525)
1. The increasing mortality burden of liver disease among opioid-dependent people: cohort study.
Gibson A; Randall D; Degenhardt L
Addiction; 2011 Dec; 106(12):2186-92. PubMed ID: 21749525
[TBL] [Abstract][Full Text] [Related]
2. The contributions of viral hepatitis and alcohol to liver-related deaths in opioid-dependent people.
Larney S; Randall D; Gibson A; Degenhardt L
Drug Alcohol Depend; 2013 Aug; 131(3):252-7. PubMed ID: 23237980
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain.
Brugal MT; Domingo-Salvany A; Puig R; Barrio G; García de Olalla P; de la Fuente L
Addiction; 2005 Jul; 100(7):981-9. PubMed ID: 15955014
[TBL] [Abstract][Full Text] [Related]
4. Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.
Stoové MA; Dietze PM; Jolley D
Drug Alcohol Rev; 2009 Jul; 28(4):347-52. PubMed ID: 19594787
[TBL] [Abstract][Full Text] [Related]
5. Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009.
Darke S; Mills KL; Ross J; Teesson M
Drug Alcohol Depend; 2011 Jun; 115(3):190-5. PubMed ID: 21130585
[TBL] [Abstract][Full Text] [Related]
6. Causes of death in a cohort treated for opioid dependence between 1985 and 2005.
Degenhardt L; Larney S; Randall D; Burns L; Hall W
Addiction; 2014 Jan; 109(1):90-9. PubMed ID: 23961881
[TBL] [Abstract][Full Text] [Related]
7. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
[TBL] [Abstract][Full Text] [Related]
8. [An 1-year prospective cohort study on mortality of injecting drug users].
Zhang L; Ruan YH; Jiang ZQ; Yang ZN; Liu SZ; Zhou F; He YX; Yin L; Qin GM; Shao YM
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Mar; 26(3):190-3. PubMed ID: 15941506
[TBL] [Abstract][Full Text] [Related]
9. Modelling and calibration of the hepatitis C epidemic in Australia.
Razali K; Amin J; Dore GJ; Law MG; HCV Projections Working Group
Stat Methods Med Res; 2009 Jun; 18(3):253-70. PubMed ID: 19036911
[TBL] [Abstract][Full Text] [Related]
10. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.
Davoli M; Bargagli AM; Perucci CA; Schifano P; Belleudi V; Hickman M; Salamina G; Diecidue R; Vigna-Taglianti F; Faggiano F;
Addiction; 2007 Dec; 102(12):1954-9. PubMed ID: 18031430
[TBL] [Abstract][Full Text] [Related]
11. Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
Walter SR; Thein HH; Amin J; Gidding HF; Ward K; Law MG; George J; Dore GJ
J Hepatol; 2011 May; 54(5):879-86. PubMed ID: 21145812
[TBL] [Abstract][Full Text] [Related]
12. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
[TBL] [Abstract][Full Text] [Related]
13. All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection.
Hernando V; Perez-Cachafeiro S; Lewden C; Gonzalez J; Segura F; Oteo JA; Rubio R; Dalmau D; Moreno S; Amo JD;
J Hepatol; 2012 Oct; 57(4):743-51. PubMed ID: 22709620
[TBL] [Abstract][Full Text] [Related]
14. Suicide and other-cause mortality among heroin users in Taiwan: a prospective study.
Lee CT; Chen VC; Tan HK; Chou SY; Wu KH; Chan CH; Gossop M
Addict Behav; 2013 Oct; 38(10):2619-23. PubMed ID: 23851391
[TBL] [Abstract][Full Text] [Related]
15. Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved.
Degenhardt L; Randall D; Hall W; Law M; Butler T; Burns L
Drug Alcohol Depend; 2009 Nov; 105(1-2):9-15. PubMed ID: 19608355
[TBL] [Abstract][Full Text] [Related]
16. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
[TBL] [Abstract][Full Text] [Related]
17. Extreme cause-specific mortality in a cohort of adult prisoners--1988 to 2002: a data-linkage study.
Kariminia A; Butler T; Corben S; Levy M; Grant L; Kaldor J; Law M
Int J Epidemiol; 2007 Apr; 36(2):310-6. PubMed ID: 17158524
[TBL] [Abstract][Full Text] [Related]
18. Mortality trends among heroin users treated between 1975 and 2013 in Northern Italy: Results of a longitudinal study.
Pavarin RM; Fioritti A; Sanchini S
J Subst Abuse Treat; 2017 Jun; 77():166-173. PubMed ID: 28237351
[TBL] [Abstract][Full Text] [Related]
19. Comparative toxicology of fatal heroin overdose cases and morphine positive homicide victims.
Darke S; Duflou J; Kaye S
Addiction; 2007 Nov; 102(11):1793-7. PubMed ID: 17784895
[TBL] [Abstract][Full Text] [Related]
20. Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia.
Gidding HF; Amin J; Dore GJ; Ward K; Law MG
J Hepatol; 2010 Jul; 53(1):43-9. PubMed ID: 20447718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
